One of the nanomedicines that are used clinically in the treatment of cancer is nanoparticle albumin-bound paclitaxel (brand name: Abraxane), which showed less toxic and superior efficacy compared with polyethylated castor oil-based paclitaxel in the treatment of breast cancer [4]. This evidence concerns the gene ALB and breast carcinoma.